IS IT THE END OF THE EXPECTATIONS VERSUS REALITY ABOUT THE ANTICANCER EFFECT OF PHOSPHOETHANOLAMINE?
DOI:
https://doi.org/10.14450/2318-9312.v29.e2.a2017.pp87-89Abstract
Desde 2015, a polêmica sobre a fosfoetanolamina tem sido foco de discussão em diversas esferas da sociedade, indo desde o debate científico até o político (1). Em 2016, escrevemos o primeiro editorial intitulado
“Expectativa e realidade em torno do efeito anticâncer da fosfoetanolamina”, no qual discutimos os problemas relacionados à substância sintética, divulgada como “medicamento milagroso”, que poderia ser utilizado em
praticamente todos os casos de câncer (2).
Downloads
Published
2017-06-30
How to Cite
Oliveira, A. G. de, & Silveira, D. (2017). IS IT THE END OF THE EXPECTATIONS VERSUS REALITY ABOUT THE ANTICANCER EFFECT OF PHOSPHOETHANOLAMINE?. Infarma - Pharmaceutical Sciences, 29(2), 87–89. https://doi.org/10.14450/2318-9312.v29.e2.a2017.pp87-89
Issue
Section
Editorial
License
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
- Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).
